首頁 > 市場調查報告書 > 醫療設備

體外診斷

病毒攜帶者篩檢市場規模、佔有率和成長分析（按檢測類型、疾病類型、醫療狀況、技術、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898499

病毒攜帶者篩檢市場規模、佔有率和成長分析（按檢測類型、疾病類型、醫療狀況、技術、最終用戶和地區分類）－2026-2033年產業預測

Carrier Screening Market Size, Share, and Growth Analysis, By Test Type (Molecular Screening Test, Biochemical Screening Test), By Disease Type, By Medical Condition, By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球病毒攜帶者篩檢市場規模預計在 2024 年達到 28.3 億美元，從 2025 年的 32 億美元成長到 2033 年的 86.4 億美元，在預測期（2026-2033 年）內複合年成長率為 13.2%。

市場分析顯示，遺傳疾病發生率的上升以及人們對預防醫學日益成長的興趣是推動全球攜帶者篩檢需求的關鍵因素。基因組技術的創新以及人們對囊腫纖維化、戴-薩克斯病和鐮狀細胞貧血等遺傳疾病認知的提高，預計將推動攜帶者篩檢的廣泛應用。此外，基因檢測的普及和有利的報銷政策有望為該領域的公司創造巨大的機會。然而，缺乏標準化、發展中地區認知度低、結果解讀複雜以及先進攜帶者篩檢技術高成本等挑戰，可能會對市場成長構成重大障礙，並影響攜帶者篩檢解決方案的整體前景。

全球載體篩檢市場促進因素

全球遺傳疾病發病率的不斷上升，以及人們對這些疾病的認知日益提高，預計將顯著推動對攜帶者篩檢服務的需求。此篩檢旨在幫助高風險族群和夫婦做出知情的生育決定，最終最大限度地降低將囊腫纖維化、戴-薩克斯病和鐮狀細胞貧血等遺傳疾病傳給後代的風險。隨著越來越多的人意識到攜帶者篩檢在遺傳風險管理方面的益處，預計該服務的市場將會成長，這反映出人們對遺傳健康和計劃生育選擇的理解不斷加深。

限制全球載體篩檢市場的因素

由於缺乏標準化的攜帶者篩檢指南和法規，不同應用情境的篩檢結果差異很大。這種不一致給尋求可靠、準確篩檢方案的醫療服務提供者和患者帶來了巨大挑戰。因此，缺乏統一性會削弱人們對攜帶者篩檢方法的信任，阻礙其在臨床環境中的廣泛應用。缺乏既定標準可能會使醫療服務提供者和患者對採用這些篩檢望而卻步，最終影響全球攜帶者篩檢市場的未來發展和成長。制定一致可靠的指南對於增強人們對這些重要篩檢工具的信心至關重要。

全球載體篩檢市場趨勢

全球攜帶者篩檢市場正呈現與數位醫療日益融合的顯著趨勢，這正在重塑企業的營運方式以及與患者的互動模式。透過整合先進的數位解決方案，攜帶者篩檢提供者正在提升患者的便利性和參與度，使篩檢流程更加便捷易用。這種無縫整合不僅簡化了營運流程，還提高了人們對攜帶者篩檢的認知度和接受度，最終推動了業務成長。隨著醫療保健產業的不斷發展，數位化工具的應用預計將在擴大攜帶者篩檢服務的全球覆蓋範圍和影響力方面發揮關鍵作用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Illumina, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
Natera, Inc.（USA）
Myriad Genetics, Inc.（USA）
Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（LabCorp）（USA）
Quest Diagnostics Incorporated（USA）
Invitae Corporation（USA）
PerkinElmer, Inc.（USA）
Fulgent Genetics（USA）
Agilent Technologies, Inc.（USA）
Genomics England（UK）
Centogene AG（Germany）
Integrated DNA Technologies, Inc.（IDT）（USA）
BGI Genomics（China）
Ambry Genetics Corporation（USA）
DNA Genotek Inc.（Canada）
GeneDx, Inc.（USA）
MedGenome Labs Pvt. Ltd.（India）

結論與建議

簡介目錄

Product Code: SQMIG35A2993

Global Carrier Screening Market size was valued at USD 2.83 Billion in 2024 and is poised to grow from USD 3.2 Billion in 2025 to USD 8.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period (2026-2033).

Market insights indicate that the growing prevalence of genetic diseases and the increasing focus on preventive healthcare are key factors propelling the demand for carrier screening globally. Innovations in genomic technologies and heightened awareness of genetic disorders, such as cystic fibrosis, Tay-Sachs, and sickle cell anemia, are expected to enhance the uptake of carrier screening. Additionally, improved accessibility to genetic testing and favorable reimbursement policies are anticipated to create significant opportunities for companies in this sector. However, challenges such as the lack of standardization, limited awareness in developing regions, complexities in result interpretation, and high costs associated with advanced carrier screening technologies pose considerable obstacles to market growth and may impact the overall outlook for carrier screening solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The rising occurrence of genetic disorders globally, coupled with heightened awareness about these conditions, is expected to significantly drive the demand for carrier screening services. This form of screening empowers individuals and couples who may be at risk to make informed decisions regarding reproduction, ultimately aiming to minimize the likelihood of passing on hereditary conditions such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia. As more people recognize the benefits of carrier screening in managing genetic risks, the market for these services is anticipated to grow, reflecting a broader understanding of genetic health and family planning options.

Restraints in the Global Carrier Screening Market

The absence of standardized guidelines or regulations for carrier screening panels leads to variability in results among different applications. This inconsistency poses significant challenges for healthcare providers and patients who seek reliable and accurate screening solutions. As a result, the lack of uniformity undermines the trust in carrier screening methods, hindering their widespread acceptance and utilization in clinical practice. Without established standards, both providers and patients may hesitate to embrace these screenings, which ultimately affects future advancements and the growth of the global carrier screening market. Consistent, reliable guidelines are essential to foster confidence in the adoption of these critical screening tools.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is increasingly witnessing a trend toward digital health integration, which is reshaping how companies operate and engage with patients. By incorporating advanced digital solutions, carrier screening providers enhance patient convenience and engagement, making the screening process more accessible and user-friendly. This seamless integration not only streamlines workflows but also fosters awareness and uptake among individuals considering carrier screening, ultimately driving business growth. As healthcare continues to evolve, the adoption of digital tools is expected to play a pivotal role in expanding the reach and impact of carrier screening services globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Carrier Screening Market Size by Test Type & CAGR (2026-2033)

Market Overview
Molecular Screening Test
Biochemical Screening Test

Global Carrier Screening Market Size by Disease Type & CAGR (2026-2033)

Market Overview
Cystic Fibrosis
Tay-Sachs
Gaucher Disease
Sickle Cell Disease
Spinal Muscular Atrophy
Other Autosomal Recessive Genetic Disorders

Global Carrier Screening Market Size by Medical Condition & CAGR (2026-2033)

Market Overview
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others

Global Carrier Screening Market Size by Technology & CAGR (2026-2033)

Market Overview
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others

Global Carrier Screening Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Reference Laboratories
Physician Offices and Clinics
Others

Global Carrier Screening Market Size & CAGR (2026-2033)

North America (Test Type, Disease Type, Medical Condition, Technology, End User)
- US
- Canada
Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fulgent Genetics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomics England (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Centogene AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (IDT) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambry Genetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DNA Genotek Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedGenome Labs Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments